Altimmune Q3 EPS $(0.15) Misses $(0.14) Estimate, Sales $0 Miss $1.400K Estimate
Benzinga Newsdesk 8 hours ago
NewsEarningsEarnings Misses
Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.14) by 15.38 percent. This is a 28.57 percent increase over losses of $(0.21) per share from the
Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.14) by 15.38 percent. This is a 28.57 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $1.000 which missed the analyst consensus estimate of $1.400 thousand by 99.93 percent. This is a 99.98 percent decrease over sales of $5.000 thousand the same period last year.